bioMmune Technologies Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | bioMmune Technologies Inc.

bioMmune Technologies Inc. | Cash Flow

No data

About bioMmune Technologies

View Profile

Address	400 Burrard Street Vancouver British Columbia V6C 3A6 Canada
Employees	-
Website	http://www.pascalbiosciences.com
Updated	07/08/2019
Pascal Biosciences Inc. is a biotechnology company, which engages in developing breakthrough treatments in the field of immuno-oncology. It focuses on the following technologies: Major Histocompatibility Complex I (MHC I), CD74 and Calcium Channel Blockers. The MHC I technology is a molecule that transports normal, abnormal and foreign protein fragments (peptides) to the surface of the cells where the fragments are then exposed to the immune system's T cells.